Patent ID: 11964977
Assignee: BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 10:
11. The compound of Formula (I) according to claim 1 or 2, wherein:, L is L1;, R′ is hydrogen or C1-C4-alkyl;, R1 is halogen, C1-C4-alkyl, C1-C4-haloalkyl, hydroxy-C1-C4-alkyl, hydroxy-C1-C4-haloalkyl, C1-C4-alkoxy-C1-C4-alkyl, C1-C4-haloalkoxy-C1-C4-alkyl, C2-C4-alkenyl, C2-C4-haloalkenyl, C2-C4-alkynyl, C2-C4-haloalkynyl, C1-C4-alkylcarbonyl, C1-C4-haloalkylcarbonyl, C1-C4-alkoxycarbonyl, C1-C4-haloalkoxycarbonyl, aminocarbonyl, C1-C4-alkylaminocarbonyl, C1-C4-haloalkylaminocarbonyl, di-C1-C4-alkylaminocarbonyl, di-C1-C6-haloalkylaminocarbonyl, optionally substituted 5- or 6-membered heteroaryl or optionally substituted 5- or 6-membered heterocyclyl containing 1 to 3 N, S or O heteroatoms or —NRaRb wherein Ra and Rb are independently H, C1-C4-alkyl or C1-C4-haloalkyl; or Ra and Rb may form, with the nitrogen to which they are attached, a 3-, 4-, 5- or 6-membered-heterocyclyl group, which may include one to three additional heteroatoms selected from the group consisting of N, O and S and may be optionally substituted;, R2 is hydrogen, halogen, —SF5, C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-alkoxy, C1-C4-haloalkoxy, C2-C4-alkenyl, C2-C4-haloalkenyl, C2-C4-alkynyl, C2-C4-haloalkynyl, optionally substituted C3-C6-cycloalkyl, C1-C4-alkylcarbonyl, C1-C4-haloalkylcarbonyl, C1-C4-alkoxycarbonyl, C1-C4-haloalkoxycarbonyl, aminocarbonyl, C1-C4-alkylaminocarbonyl, C1-C4-haloalkylaminocarbonyl, di-C1-C4-alkylaminocarbonyl, di-C1-C4-haloalkylaminocarbonyl, —SOp (optionally substituted C1-C4-alkyl or C1-C4-haloalkyl), or —NRaRb wherein Ra and Rb are independently H, C1-C4-alkyl or C1-C4-haloalkyl;, R3 is C1-C6-alkyl, C1-C6-haloalkyl, optionally substituted C3-C8-cycloalkyl, C1-C4-alkylcarbonyl, C1-C4-haloalkylcarbonyl, C1-C4-alkoxycarbonyl, C1-C4-haloalkoxycarbonyl, aminocarbonyl, C1-C4-alkylaminocarbonyl, C1-C4-haloalkylaminocarbonyl, di-C1-C4-alkylaminocarbonyl, di-C1-C4-haloalkylaminocarbonyl, —SOp (optionally substituted C1-C4-alkyl or C1-C4-haloalkyl), —SF5, optionally substituted 3- to 7-membered heterocyclyl containing from one to three heteroatoms selected from the group consisting of N, O and S; optionally substituted phenyl, optionally substituted 5- or 6-membered heteroaryl, a 5- to 11-membered spirocyclic heterocyclyl-carbocyclyl group, a 5- to 11-membered spirocyclic heterocyclyl-heterocyclyl group, a 5- to 11-membered spirocyclic carbocyclyl-carbocyclyl group, wherein each ring of said spirocyclic group contains 3, 4, 5 or 6 ring atoms; or —NRaRb wherein Ra and Rb are independently H, C1-C4-alkyl or C1-C4-haloalkyl; or Ra and Rb may form, with the nitrogen to which they are attached, a 3-, 4-, 5-, 6-, 7-, or 8-membered-heterocyclyl group, which may include one to three additional heteroatoms selected from the group consisting of N, O and S and may be optionally substituted;, R4 is independently in each occurrence, hydrogen, halogen, —SF5, C1-C6-alkyl, C1-C4-haloalkyl, C1-C4-alkoxy, C1-C4-haloalkoxy, —SOp (optionally substituted C1-C4-alkyl or C1-C4-haloalkyl), or —NRcRd wherein Rc and Rd are independently H, C1-C4-alkyl or C1-C4-haloalkyl;, R8 is hydrogen, halogen, C1-C4-alkyl or C1-C4-haloalkyl;, X is O or S;, Z is O; and, W is CR5R6.